This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Solid Q4 Earnings Boost Insurance ETFs
by Sweta Killa
The string of solid fourth-quarter earnings from the insurance industry players had a positive impact on the related ETFs that saw smooth trading over the past week.
Has MetLife (MET) Outpaced Other Finance Stocks This Year?
by Zacks Equity Research
Is (MET) Outperforming Other Finance Stocks This Year?
MetLife (MET) Q4 Earnings & Revenues Top Estimates, Rise Y/Y
by Zacks Equity Research
MetLife's (MET) Q4 earnings reflect gains from increase in premiums and net investment income partly offset by rise in expenses.
Is MetLife (MET) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
MetLife (MET) to Post Q4 Earnings: What's in the Offing?
by Zacks Equity Research
MetLife (MET) Q4 results are likely to reflect gains from premium in the United States, EMEA, and Latin America, partly offset by premium decline in Asia.
Why Earnings Season Could Be Great for MetLife (MET)
by Zacks Equity Research
MetLife (MET) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings.
What Awaits Cincinnati Financial (CINF) in Q4 Earnings?
by Zacks Equity Research
Cincinnati Financial (CINF) Q4 performance is likely to have benefited from price increase and premium growth initiatives.
Will Increase in Premiums Aid Allstate (ALL) Q4 Earnings?
by Zacks Equity Research
Allstate's (ALL) Q4 results are likely to reflect increase in premium, partly offset by impairment and catastrophe charges.
Chubb (CB) to Report Q4 Earnings: What's in the Offing?
by Zacks Equity Research
Chubb (CB) Q4 performance is likely to have benefited from premium growth in its Property and Casualty business, partly offset by loss in Agricultural business and catastrophes.
Prudential (PRU) to Report Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Prudential Financial's (PRU) Q4 performance is likely to have benefited from growth in asset-based businesses, solid international operations and pension risk transfer business.
3 Top Dividend Stocks to Maximize Your Retirement Income - January 31, 2020
by Zacks Equity Research
The traditional approaches to retirement planning are longer covering all expenses in nest egg years. So what can retirees do? Thankfully, there are alternative investments that provide steady, higher-rate income streams to replace dwindling bond yields.
MetLife (MET) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
MetLife (MET) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
3 Top-Ranked Dividend Stocks: A Smarter Way to Boost Your Retirement Income - January 24, 2020
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Should Value Investors Buy MetLife (MET) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Prudential's (PRU) Unit Expands Travel Assistance Offerings
by Zacks Equity Research
Prudential's (PRU) arm chooses IMG to upgrade its travel assistance suite and a new insurance product.
Why is Hold Strategy Appropriate for CNO Financial (CNO) Now?
by Zacks Equity Research
Riding high on its growing top line, reducing costs and an impressive capital position, CNO Financial (CNO) is well placed to benefit its investors.
Zacks Value Trader Highlights: Brighthouse Financial, Credit Suisse, MetLife, Penn National Gaming and Signet
by Zacks Equity Research
Zacks Value Trader Highlights: Brighthouse Financial, Credit Suisse, MetLife, Penn National Gaming and Signet
Where to Find the Best Classic Value Stocks Right Now
by Tracey Ryniec
Growth stocks continue to be sizzling hot in 2020 but value investors shouldn't despair. There are still stocks with attractive fundamentals and great Zacks Ranks.
3 Top Dividend Stocks to Maximize Your Retirement Income - January 09, 2020
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Avoid AIG, Add These 3 Insurance Stocks to Your Portfolio
by Srijita Guha
While AIG's headwinds weigh on its margins, other industry players look attractive with high prospects.
Add These 3 High Yield Dividend Stocks to Portfolio for 2020
by Swayta Shah
High yield dividend stocks are an attractive investment option for income investors.
MetLife Hits New 52-Week High: What's Driving the Rally?
by Sapna Bagaria
MetLife (MET) benefits from recent deals and strong operating performance.
Is MetLife (MET) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
3 Top Dividend Stocks to Maximize Your Retirement Income - January 03, 2020
by Zacks Equity Research
The traditional ways to plan for your retirement may mean income can no longer cover expenses post-employment. But what if there was another option that could provide a steady, reliable source of income in your nest egg years?
Cigna Considers Divesting Its Non-Health Insurance Business
by Zacks Equity Research
Speculations ran rife that Cigna (CI) is on the lookout of a bidder for its non-health insurance arm to streamline in-house operations.